ClearPoint Neuro, Inc. Tax Withholding Paid on Stock Awards
ClearPoint Neuro, Inc. (CLPT) reported Tax Withholding Paid on Stock Awards of $1.99 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-03
- ClearPoint Neuro, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- ClearPoint Neuro, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $1.99M, a 52.72% increase year-over-year.
- ClearPoint Neuro, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $195.00K, a 132.14% increase year-over-year.
- ClearPoint Neuro, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ClearPoint Neuro, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $1.86M, a 337.74% increase from fiscal 2024.
- ClearPoint Neuro, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $424.00K, a 101.90% increase from fiscal 2023.
- ClearPoint Neuro, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $210.00K, a 37.50% decline from fiscal 2022.
- ClearPoint Neuro, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $336.00K, a 43.91% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $1.99M 10-Q · filed 2026-08-03 | $2.19M derived: sum of 3 quarters · filed 2026-08-03 | $2.19M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $1.99M 10-Q · filed 2026-05-13 | $2.19M derived: sum of 2 quarters · filed 2026-05-13 | $2.19M derived: sum of 3 quarters · filed 2026-05-13 | $2.54M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $195.00K derived: sum of 2 quarters · filed 2026-03-17 | $551.00K derived: sum of 3 quarters · filed 2026-08-03 | $1.86M 10-K · filed 2026-03-17 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $356.00K derived: sum of 2 quarters · filed 2026-08-03 | $1.66M 10-Q · filed 2025-11-06 | $1.75M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $1.66M 10-Q · filed 2026-08-03 | $1.75M derived: sum of 3 quarters · filed 2026-08-03 | $1.81M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $1.30M 10-Q · filed 2026-05-13 | $1.39M derived: sum of 2 quarters · filed 2026-05-13 | $1.45M derived: sum of 3 quarters · filed 2026-05-13 | $1.58M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $145.00K derived: sum of 2 quarters · filed 2026-03-17 | $273.00K derived: sum of 3 quarters · filed 2026-03-17 | $424.00K 10-K · filed 2026-03-17 |
| 2024-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $189.00K derived: sum of 2 quarters · filed 2025-11-06 | $340.00K 10-Q · filed 2025-11-06 | $377.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $279.00K 10-Q · filed 2025-08-12 | $316.00K derived: sum of 3 quarters · filed 2025-08-12 | $407.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $151.00K 10-Q · filed 2025-05-13 | $188.00K derived: sum of 2 quarters · filed 2025-05-13 | $279.00K derived: sum of 3 quarters · filed 2025-05-13 | $356.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $128.00K derived: sum of 2 quarters · filed 2025-02-26 | $205.00K derived: sum of 3 quarters · filed 2025-02-26 | $210.00K 10-K · filed 2025-02-26 |
| 2023-09-30 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $168.00K derived: sum of 2 quarters · filed 2024-11-07 | $173.00K 10-Q · filed 2024-11-07 | $173.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $82.00K 10-Q · filed 2024-08-07 | $82.00K derived: sum of 3 quarters · filed 2024-08-07 | $418.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $5.00K 10-Q · filed 2024-05-07 | $5.00K derived: sum of 2 quarters · filed 2024-05-07 | $341.00K derived: sum of 3 quarters · filed 2024-05-07 | $341.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $336.00K derived: sum of 2 quarters · filed 2024-03-12 | $336.00K derived: sum of 3 quarters · filed 2024-03-12 | $336.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $336.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $336.00K derived: sum of 2 quarters · filed 2023-11-09 | $336.00K 10-Q · filed 2023-11-09 | $393.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $57.00K derived: sum of 3 quarters · filed 2023-08-08 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $57.00K derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $599.00K 10-K · filed 2023-03-01 | ||
| 2021-09-30 | $542.00K 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |